Medical device recalls Moderate risk

Fisher Diagnostics recalls Pacific Hemostasis Thromboplastin-D, 4 ml. Used in performing one-stage prothrombin time test and factor assays.

Recall date
March 6, 2025
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-1502-2025
FDA classification
Class II
Brand / firm
Fisher Diagnostics
Sold / distributed
US Distribution to: PA and OUS Foreign country of: United Arab Emirates.

Why it was recalled

The incorrect value of the International Sensitivity Index (ISI) is printed on the outer box label.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Pacific Hemostasis Thromboplastin-D, 4 ml. Used in performing one-stage prothrombin time test and factor assays.

Get recall alerts

Free email alert whenever Fisher Diagnostics has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Fisher Diagnostics